CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 151 filers reported holding CHEMOCENTRYX INC in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $467,000 | +418.9% | 33,500 | +10.2% | 0.03% | +520.0% |
| Q2 2022 | $90,000 | -88.3% | 30,400 | -63.6% | 0.01% | -83.9% |
| Q1 2022 | $766,000 | -29.7% | 83,536 | +0.5% | 0.03% | +3.3% |
| Q4 2021 | $1,090,000 | -15.3% | 83,152 | -16.0% | 0.03% | -26.8% |
| Q3 2021 | $1,287,000 | +53.6% | 99,016 | -46.1% | 0.04% | +51.9% |
| Q2 2021 | $838,000 | -82.7% | 183,609 | -67.9% | 0.03% | -89.8% |
| Q2 2020 | $4,831,000 | +1230.9% | 572,000 | +467.5% | 0.26% | +1004.2% |
| Q1 2020 | $363,000 | – | 100,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
| Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
| HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
| Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
| Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
| Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
| Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
| Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
| Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |